NCT04451109Active, not recruiting
Dilapan-S®: A Multicenter US E-registry
Source: ClinicalTrials.gov · Last updated 22 Nov 2024
Brief summary (registry, in English)
Objective of this registry is to collect a representative set of real world data on the use of Dilapan-S® for pre-induction cervical ripening in daily clinical practice. Upon completion of the registry, relevant collected data will be analyzed and published.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1200 (estimated)
- First submitted
- 17 Jun 2020
- Start date
- 1 Dec 2020
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Medicem Technology s.r.o.
- Diseases
- High blood pressure
- NCT number
- NCT04451109
What you commit to
- Study type: Observational
- Planned participants: 1200
- From 1 Dec 2020 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Data not available for extraction
Who the study is looking for
- Pregnant woman whose plan of care is induction of labor
- Maternal age ≥ 18 years
- Gestational age ≥ 37 +0/7 weeks
- Dilapan-S® used for cervical ripening
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas Medical Branch Coordinator of this site? Confirm its status | Galveston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.